Mark A. Marzinke

Also affiliated with Johns Hopkins Medicine

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 60 papers. Top paper: “Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women”.

Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women

New England Journal of Medicine(2021)10.1056/nejmoa2101016

N/A

8.3DataRank · unranked

869 citations

Deborah Donnell, Meredith E. Clement, Brett Hanscom, Leslie Cottle, Lara E. Coelho +60 more

Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial

The Lancet(2022)10.1016/s0140-6736(22)00538-4

N/A

7.4DataRank · unranked

552 citations

James P. Hughes, Peter Bock, Samuel Gurrion Ouma, Portia Hunidzarira, Dishiki Kalonji +95 more

Efficacy and safety of long-acting cabotegravir compared with daily oral tenofovir disoproxil fumarate plus emtricitabine to prevent HIV infection in cisgender men and transgender women who have sex with men 1 year after study unblinding: a secondary analysis of the phase 2b and 3 HPTN 083 randomised controlled trial

The Lancet HIV(2023)10.1016/s2352-3018(23)00261-8

N/A

2.0DataRank · unranked

68 citations

Brett Hanscom, Meredith E. Clement, Trần Việt Hà, Esper G. Kallás, Manya Magnus +25 more

Safety and pharmacokinetics of oral and long-acting injectable cabotegravir or long-acting injectable rilpivirine in virologically suppressed adolescents with HIV (IMPAACT 2017/MOCHA): a phase 1/2, multicentre, open-label, non-comparative, dose-finding study

The Lancet HIV(2024)10.1016/s2352-3018(23)00300-4

N/A

1.1DataRank · unranked

29 citations

Edmund V. Capparelli, Katherine Calabrese, Kristin Baltrusaitis, Mark A. Marzinke, Cynthia McCoig +36 more

Randomized, placebo controlled phase I trial of the safety, pharmacokinetics, pharmacodynamics and acceptability of a 90 day tenofovir plus levonorgestrel vaginal ring used continuously or cyclically in women: The CONRAD 138 study

PLoS ONE(2022)10.1371/journal.pone.0275794

N/A

0.665DataRank · unranked

18 citations

Vivian Brache, Leila Cochón, Louise A. Ouattara, Neelima Chandra, Terry A. Jacot +14 more

Vaginal Microbiota and Mucosal Pharmacokinetics of Tenofovir in Healthy Women Using a 90-Day Tenofovir/Levonorgestrel Vaginal Ring

Frontiers in Cellular and Infection Microbiology(2022)10.3389/fcimb.2022.799501

N/A

0.603DataRank · unranked

21 citations

Jacques Ravel, Pawel Gajer, Mark A. Marzinke, Louise A. Ouattara, Terry A. Jacot +4 more

Efficacy, safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir for HIV pre-exposure prophylaxis in transgender women: a secondary analysis of the HPTN 083 trial

The Lancet HIV(2023)10.1016/s2352-3018(23)00200-x

N/A

0.580DataRank · unranked

14 citations

Brett Hanscom, Zhe Wang, Steven A. Safren, Christina Psaros, Deborah Donnell +61 more

Updating the Adherence–Response for Oral Emtricitabine/Tenofovir Disoproxil Fumarate for Human Immunodeficiency Virus Pre-Exposure Prophylaxis Among Cisgender Women

Clinical Infectious Diseases(2023)10.1093/cid/ciad021

N/A

0.546DataRank · unranked

37 citations

Mark A. Marzinke, David V. Glidden, Peter L. Anderson

Tenofovir Douche as HIV Preexposure Prophylaxis for Receptive Anal Intercourse: Safety, Acceptability, Pharmacokinetics, and Pharmacodynamics (DREAM 01)

The Journal of Infectious Diseases(2023)10.1093/infdis/jiad535

N/A

0.542DataRank · unranked

17 citations

Ian McGowan, Peter A. Anton, Edward J. Fuchs, Ken Ho, Alex Carballo‐Diéguez +20 more

Safety of combined long-acting injectable cabotegravir and long-acting injectable rilpivirine in virologically suppressed adolescents with HIV (IMPAACT 2017/MOCHA): a phase 1/2, multicentre, open-label, non-comparative, dose-finding study

The Lancet HIV(2025)10.1016/s2352-3018(24)00344-8

N/A

0.535DataRank · unranked

12 citations

Kristin Baltrusaitis, Brookie M. Best, Jack Moye, Ellen Townley, Avy Violari +36 more

Safety and drug quantification of the dapivirine vaginal ring and oral pre-exposure prophylaxis in breastfeeding mother–infant pairs (MTN-043): a phase 3B, open-label, randomised trial

The Lancet HIV(2025)10.1016/s2352-3018(24)00306-0

N/A

0.518DataRank · unranked

13 citations

Maxensia Owor, Nyaradzo Mgodi, Brenda Gati Mirembe, Sufia Dadabhai, Elizea Horne +14 more

Extended Analysis of HIV Infection in Cisgender Men and Transgender Women Who Have Sex with Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083

Antimicrobial Agents and Chemotherapy(2023)10.1128/aac.00053-23

N/A

0.510DataRank · unranked

29 citations

Jessica M. Fogel, Zhe Wang, Estelle Piwowar‐Manning, Ryan Kofron, Amber Moser +24 more

Fundamental aspects of long-acting tenofovir alafenamide delivery from subdermal implants for HIV prophylaxis

Scientific Reports(2022)10.1038/s41598-022-11020-2

N/A

0.449DataRank · unranked

19 citations

Mariana Remedios-Chan, Debbie Sanchez, Simon G. Webster, Amalia E. Castonguay, Paul Webster +13 more

Evaluation of long‐acting cabotegravir safety and pharmacokinetics in pregnant women in eastern and southern Africa: a secondary analysis of HPTN 084

Journal of the International AIDS Society(2025)10.1002/jia2.26401

N/A

0.442DataRank · unranked

18 citations

Brett Hanscom, Xu Guo, Clemensia Nkabiito, Patricia Mandima, Patricia Ntege Nahirya +17 more

Preventive efficacy of a tenofovir alafenamide fumarate nanofluidic implant in SHIV-challenged nonhuman primates

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.05.13.091694

N/A

0.434DataRank · unranked

17 citations

Antons Sizovs, Kathryn A. Shelton, Zoha Momin, Lane R. Bushman, Jiaqiong Xu +13 more

Nimodipine improves cortical efficiency during working memory in healthy subjects

Translational Psychiatry(2020)10.1038/s41398-020-01066-z

N/A

0.434DataRank · unranked

17 citations

Mellissa Giegerich, Greer Prettyman, Kayla E. Carta, Marcus van Ginkel, Molly P. O’Rourke +11 more

Correlates of self-reported and biomarker based adherence to daily oral HIV pre-exposure prophylaxis among a cohort of predominantly men who have sex with men in Nigeria

PLoS ONE(2023)10.1371/journal.pone.0282999

N/A

0.421DataRank · unranked

8 citations

Rebecca G. Nowak, Mark A. Marzinke, Daniel J. Morgan, Nadia A. Sam‐Agudu, Jaih Craddock +8 more

Higher colorectal tissue HIV infectivity in cisgender women compared with MSM before and during oral preexposure prophylaxis

AIDS(2021)10.1097/qad.0000000000002907

N/A

0.385DataRank · unranked

12 citations

Ian McGowan, Krista Yuhas, Rhonda M. Brand, Mark A. Marzinke, Yukari C. Manabe +15 more

A population pharmacokinetic model based on HPTN 077 of long‐acting injectable cabotegravir for HIV PrEP

British Journal of Clinical Pharmacology(2022)10.1111/bcp.15477

N/A

0.373DataRank · unranked

11 citations

Kristin L. Bigos, Mark A. Marzinke, Raphael J. Landovitz, Marybeth McCauley, Susan L. Ford +5 more

Acceptability of a Dapivirine/Placebo Gel Administered Rectally to HIV-1 Seronegative Adults (MTN-026)

AIDS and Behavior(2021)10.1007/s10461-021-03490-8

N/A

0.326DataRank · unranked

6 citations

Ryan C. Tingler, Clara Domínguez, Eileen F. Dunne, Craig Hoesley, Ken Ho +20 more

Prevalence of SARS-CoV-2 Infection among Children and Adults in 15 US Communities, 20211

Emerging Infectious Diseases(2024)10.3201/eid3002.230863

N/A

0.292DataRank · unranked

6 citations

Timothy Skalland, Ayana Moore, Christopher I. Amos, Mark A. Marzinke, Sahar Z. Zangeneh +27 more

Preclinical Considerations for Long-acting Delivery of Tenofovir Alafenamide from Subdermal Implants for HIV Pre-exposure Prophylaxis

Pharmaceutical Research(2022)10.1007/s11095-022-03440-6

N/A

0.292DataRank · unranked

6 citations

Mariana Remedios-Chan, Debbie Sanchez, Rob Fanter, Simon G. Webster, Paul Webster +9 more

High Isoniazid Exposures When Administered with Rifapentine Once Weekly for Latent Tuberculosis in Individuals with Human Immunodeficiency Virus

Antimicrobial Agents and Chemotherapy(2023)10.1128/aac.01297-22

N/A

0.269DataRank · unranked

4 citations

Yuri F. van der Heijden, Matthew S. Shotwell, Violet Chihota, Mark A. Marzinke, Richard E. Chaisson +3 more

Clinical trial simulation to evaluate tenofovir disoproxil fumarate/emtricitabine HIV pre-exposure prophylaxis dosing during pregnancy

Frontiers in Reproductive Health(2023)10.3389/frph.2023.1224580

N/A

0.241DataRank · unranked

4 citations

Yifan Yu, Mark A. Marzinke, Jenell S. Coleman, Craig W. Hendrix, Robert R. Bies +1 more

Safety outcomes among infants whose mothers used the dapivirine vaginal ring or oral PrEP during pregnancy (MTN-042/DELIVER): a randomised phase 3b study

The Lancet HIV(2025)10.1016/s2352-3018(25)00261-9

N/A

0.208DataRank · unranked

3 citations

Daniel Szydlo, Ashley Mayo, Katie Bunge, Felix Mhlanga, Jeanna Piper +57 more

Assessing Per-Sex-Act HIV-1 Risk Reduction Among Women Using the Dapivirine Vaginal Ring

The Journal of Infectious Diseases(2023)10.1093/infdis/jiad550

N/A

0.173DataRank · unranked

2 citations

Tracy Qi Dong, Craig W. Hendrix, Thesla Palanee‐Phillips, Ariane van der Straten, Sharon L. Hillier +22 more

Pharmacologic evaluation of delayed long-acting cabotegravir administration among cisgender women in HPTN 084

Antimicrobial Agents and Chemotherapy(2024)10.1128/aac.00994-24

N/A

0.165DataRank · unranked

2 citations

Kelong Han, Brett Hanscom, Xu Guo, Estelle Piwowar-Manning, Craig W. Hendrix +14 more

Evaluation of a Multidrug Assay for Monitoring Adherence to a Regimen for HIV Preexposure Prophylaxis in a Clinical Study, HIV Prevention Trials Network 073

UNC Libraries(2020)10.17615/5mda-3h63

N/A

0.104DataRank · unranked

1 citations

Scott Rose, Sheldon D. Fields, Lynda Emel, Marc Siegel, Geetha Beauchamp +11 more

Efficacy and safety of long-acting cabotegravir compared with daily oral tenofovir disoproxil fumarate plus emtricitabine to prevent HIV infection in cisgender men and transgender women who have sex with men 1 year after study unblinding: a secondary analysis of the phase 2b and 3 HPTN 083 randomised controlled trial

UNC Libraries(2025)10.17615/8yt1-yt24

N/A

0.104DataRank · unranked

1 citations

Beatriz Grinsztejn, Omar Sued, Adeola Adeyeye, Estelle Piwowar‐Manning, Meredith E. Clement +26 more

Development and validation of assays for the quantification of β-D-N4-hydroxycytidine in human plasma and β-D-N4-hydroxycytidine-triphosphate in peripheral blood mononuclear cell lysates

Journal of Chromatography B(2021)10.1016/j.jchromb.2021.122921

N/A

0DataRank · unranked

30 citations

Lindsay A. Kryszak, Mark A. Marzinke, Teresa L. Parsons

Characterization of Human Immunodeficiency Virus (HIV) Infections in Women Who Received Injectable Cabotegravir or Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Prevention: HPTN 084

The Journal of Infectious Diseases(2021)10.1093/infdis/jiab576

N/A

0DataRank · unranked

69 citations

Jessica M. Fogel, Estelle Piwowar‐Manning, Gordon Chau, Vanessa Cummings, Yaw Agyei +28 more

Characterization of Human Immunodeficiency Virus (HIV) Infection in Cisgender Men and Transgender Women Who Have Sex With Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083

The Journal of Infectious Diseases(2021)10.1093/infdis/jiab152

N/A

0DataRank · unranked

132 citations

Beatriz Grinsztejn, Jessica M. Fogel, Estelle Piwowar‐Manning, Maoji Li, Lei Weng +25 more

The development and validation of a method using high-resolution mass spectrometry (HRMS) for the qualitative detection of antiretroviral agents in human blood

UNC Libraries(2020)10.17615/4qkc-2247

N/A

0DataRank · unranked

0 citations

Estelle Piwowar‐Manning, Teresa L. Parsons, Myron S. Cohen, William R. Clarke, Susan H. Eshleman +2 more

Development and validation of a liquid chromatographic-tandem mass spectrometric assay for the quantification of cabotegravir and rilpivirine from dried blood spots

Journal of Pharmaceutical and Biomedical Analysis(2023)10.1016/j.jpba.2023.115307

N/A

0DataRank · unranked

9 citations

Teresa L. Parsons, Ryann Gollings, Marybeth McCauley, Beatriz Grinsztejn, Raphael J. Landovitz +2 more

Novel Dosing Strategies Increase Exposures of the Potent Antituberculosis Drug Rifapentine but Are Poorly Tolerated in Healthy Volunteers

UNC Libraries(2020)10.17615/48tz-4826

N/A

0DataRank · unranked

0 citations

Evelyn Hogg, Constance A. Benson, Kristine Y. Patterson, Jennifer Janik, Richard Hafner +8 more

Development and validation of a multiplexed assay for the measurement of long-acting hormonal contraceptives in plasma via liquid chromatography-tandem mass spectrometry

Journal of Pharmaceutical and Biomedical Analysis(2023)10.1016/j.jpba.2023.115321

N/A

0DataRank · unranked

1 citations

Teresa L. Parsons, Ryann Gollings, Aashish Pandey, Mark A. Marzinke, Claire E. Knezevic

Reply to Niu and Drain

Clinical Infectious Diseases(2023)10.1093/cid/ciad486

N/A

0DataRank · unranked

0 citations

Mark A. Marzinke, David V. Glidden, Peter L. Anderson

Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women

UNC Libraries(2023)10.17615/2a0s-sa46

N/A

0DataRank · unranked

0 citations

B. Grinsztejn, Patrick Gonzales, S. Chariyalertsak, Nirupama Sista, Peter K Anderson +61 more

Features of HIV Infection in the Context of Long-Acting Cabotegravir Preexposure Prophylaxis

New England Journal of Medicine(2024)10.1056/nejmc2402088

N/A

0DataRank · unranked

35 citations

Sinéad Delany‐Moretlwe, Jessica M. Fogel, Mark A. Marzinke, Estelle Piwowar-Manning, Paul A. Richardson +15 more

Hypoglycemic risk exposures in relation to low serum glucose values in ambulatory patients

Medicine(2020)10.1097/md.0000000000018679

N/A

0DataRank · unranked

3 citations

Mark A. Marzinke, Aditya Ashok, Karen C. Carroll, Kyrstin Lane, Rebecca Jeun +4 more

Phase 1 randomized trials to assess safety, pharmacokinetics, and vaginal bleeding associated with use of extended duration dapivirine and levonorgestrel vaginal rings

PLoS ONE(2024)10.1371/journal.pone.0304552

N/A

0DataRank · unranked

7 citations

Clifton W. Kelly, Craig Hoesley, Diana Blithe, Jill Brown, Barbra A. Richardson +11 more

HIV DNA Levels in Persons Who Acquired HIV in the Setting of Long-Acting Cabotegravir for HIV Prevention: Analysis of Cases from HPTN 083 and 084

AIDS Research and Human Retroviruses(2024)10.1089/aid.2024.0049

N/A

0DataRank · unranked

5 citations

Deborah Persaud, Estelle Piwowar‐Manning, Paul Richardson, Joseph Szewczyk, Mark A. Marzinke +19 more

Pharmacokinetics of tenofovir alafenamide, emtricitabine, and dolutegravir in a patient on peritoneal dialysis

AIDS Research and Therapy(2024)10.1186/s12981-024-00616-5

N/A

0DataRank · unranked

2 citations

Mohamed G. Atta, Chloe L. Thio, Jeffrey A. Tornheim, Edward J. Fuchs, Rahul P. Bakshi +4 more

Rapid and sensitive liquid chromatographic–tandem mass spectrometric methods for the quantitation of dolutegravir in human plasma and breast milk

Journal of Mass Spectrometry and Advances in the Clinical Lab(2024)10.1016/j.jmsacl.2024.09.001

N/A

0DataRank · unranked

0 citations

Aashish Pandey, Amelia L Price, Mark A. Marzinke, Ashley R Rackow

Comparison of etonogestrel bioanalytical assay results in plasma and serum within and across laboratories

Contraception(2024)10.1016/j.contraception.2024.110720

N/A

0DataRank · unranked

0 citations

Lee C. Winchester, Christopher Wichman, Sean N. Avedissian, David W. Erikson, Molly Kernan +10 more

Safety and tolerability of injectable Rilpivirine LA in HPTN 076: A phase 2 HIV pre-exposure prophylaxis study in women

EClinicalMedicine(2020)10.1016/j.eclinm.2020.100303

N/A

0DataRank · unranked

24 citations

SHUANGLING LI, Subash Pathak, Elizabeth E. Tolley, Mark A. Marzinke, Jessica Justman +13 more

Phase 2 Study of the Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in Men Who Have Sex With Men (HPTN 069/ACTG A5305)

eScholarship (California Digital Library)(2020)10.17615/m2r7-rg29

N/A

0DataRank · unranked

28 citations

Ian Frank, Susan H. Eshleman, Ken Ho, Robert A. Salata, Jorge Santana +24 more

Antiretroviral drug use and HIV drug resistance in female sex workers in Tanzania and the Dominican Republic

PLoS ONE(2020)10.1371/journal.pone.0240890

N/A

0DataRank · unranked

10 citations

Jessica M. Fogel, Noya Galai, William Clarke, Autumn Breaud, Mark A. Marzinke +10 more

Recommendations for Interpreting Intraerythrocytic Tenofovir Diphosphate and Emtricitabine Triphosphate for HIV-1 Preexposure Prophylaxis Adherence Assessment

JAIDS Journal of Acquired Immune Deficiency Syndromes(2025)10.1097/qai.0000000000003715

N/A

0DataRank · unranked

5 citations

Corwin Coppinger, Mackenzie L. Cottrell, Mark A. Marzinke, Peter L. Anderson

Viral load Reduction in SHIV-Positive Nonhuman Primates via Long-Acting Subcutaneous Tenofovir Alafenamide Fumarate Release from a Nanofluidic Implant

Pharmaceutics(2020)10.3390/pharmaceutics12100981

N/A

0DataRank · unranked

105 citations

Nicola Di Trani, Antons Sizovs, Kathryn A. Shelton, Zoha Momin, Lane R. Bushman +13 more

Estimation of Prevention-Effective CAB-LA Concentrations Among Men Who Have Sex With Men (MSM) and Transgender Women (TGW) in HPTN 083

The Journal of Infectious Diseases(2025)10.1093/infdis/jiaf561

N/A

0DataRank · unranked

2 citations

Mark A. Marzinke, Xinnong Li, Deborah Donnell, Robert R. Bies, Craig W. Hendrix +16 more

Efficacy, safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir for HIV pre-exposure prophylaxis in transgender women: a secondary analysis of the HPTN 083 trial

UNC Libraries(2025)10.17615/9zee-gb05

N/A

0DataRank · unranked

0 citations

Beatriz Grinsztejn, Mark A. Marzinke, Brett Hanscom, Alex R. Rinehart, Susan H. Eshleman +26 more

Use of DNA profiling to resolve HIV status in a person using injectable cabotegravir for HIV pre-exposure prophylaxis

Journal of Clinical Pathology(2025)10.1136/jcp-2025-210202

N/A

0DataRank · unranked

0 citations

Mahdi Salih, Kathy Haddaway, Mark A. Marzinke, Christi E. Marshall, Zhe Wang +8 more

Sustained HIV Suppression With Co-formulated Tenofovir Disoproxil Fumarate/Lamivudine/Dolutegravir in a Person With Transmitted Dolutegravir Resistance and Pretreatment Resistance to Lamivudine: a Case Report From HPTN 083

Open Forum Infectious Diseases(2025)10.1093/ofid/ofaf645

N/A

0DataRank · unranked

0 citations

Jessica M. Fogel, Mark A. Marzinke, Elias K. Halvas, Urvi M. Parikh, John W. Mellors +15 more

Evaluation of pharmacokinetic interactions between long‐acting cabotegravir or emtricitabine/tenofovir disoproxil fumarate and hormonal contraceptive agents: a tertiary analysis of South African participants in HPTN 084

Journal of the International AIDS Society(2025)10.1002/jia2.70056

N/A

0DataRank · unranked

0 citations

Brett Hanscom, Daniel Haines, Kimberly K. Scarsi, Yaw Agyei, Estelle Piwowar‐Manning +17 more

Interaction of Depot Medroxyprogesterone Acetate and Tenofovir Disoproxil Fumarate/Emtricitabine on Peripheral Blood Mononuclear Cells and Cervical Tissue Susceptibility to HIV Infection and Pharmacokinetics

JAIDS Journal of Acquired Immune Deficiency Syndromes(2022)10.1097/qai.0000000000003113

N/A

0DataRank · unranked

4 citations

Clarissa P. Diniz, Edward J. Fuchs, Mark A. Marzinke, Wutyi Aung, Rahul P. Bakshi +10 more

Urine Tenofovir Levels Measured Using a Novel Immunoassay Predict Human Immunodeficiency Virus Protection

Clinical Infectious Diseases(2020)10.1093/cid/ciaa785

N/A

0DataRank · unranked

21 citations

Jared M. Baeten, Deborah Donnell, Matthew A. Spinelli, David V. Glidden, Warren C. Rodrigues +28 more

Hypo-osmolar rectal douche tenofovir formulation prevents simian/human immunodeficiency virus acquisition in macaques

JCI Insight(2022)10.1172/jci.insight.161577

N/A

0DataRank · unranked

2 citations

Sanjeev Gumber, Mark A. Marzinke, Thuy Hoang, Rohan Myers, Abhijit A. Date +9 more

HIV RNA Screening Reduces Integrase Strand Transfer Inhibitor Resistance Risk in Persons Receiving Long-Acting Cabotegravir for HIV Prevention

The Journal of Infectious Diseases(2022)10.1093/infdis/jiac415

N/A

0DataRank · unranked

36 citations

Jessica M. Fogel, Elias K. Halvas, Estelle Piwowar‐Manning, Mark A. Marzinke, Ryan Kofron +25 more

Bone changes with candidate PrEP regimens containing tenofovir disoproxil fumarate and/or maraviroc and/or emtricitabine in US men and women: HPTN 069/ACTG A5305

Journal of Antimicrobial Chemotherapy(2021)10.1093/jac/dkab400

N/A

0DataRank · unranked

5 citations

Krista Yuhas, Kenneth H. Mayer, Raphael J. Landovitz, Mark A. Marzinke, Craig W. Hendrix +7 more